PHINIA (PHIN) director awarded 41 deferred stock units and now holds 8,551 DRSUs
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Weerasinghe Rohan reported acquisition or exercise transactions in this Form 4 filing.
PHINIA Inc. director Rohan Weerasinghe received a grant of 41 deferred restricted stock units (DRSUs) on March 20, 2026. Each DRSU is economically equivalent to one share of common stock and will vest on the one-year anniversary of the grant date under the company’s Director Deferred Compensation Program and 2023 Stock Incentive Plan.
After this grant, Weerasinghe holds 8,551 DRSUs and directly holds 22,686 shares of PHINIA common stock, with an additional 12 shares held indirectly through a managed account. The grant is a compensation-related award, not an open-market purchase.
Positive
- None.
Negative
- None.
Insider Trade Summary
3 transactions reported
Mixed
3 txns
Insider
Weerasinghe Rohan
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Deferred Restricted Stock Units | 41 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Deferred Restricted Stock Units — 8,551 shares (Direct);
Common Stock — 22,686 shares (Direct);
Common Stock — 12 shares (Indirect, By Managed Account)
Footnotes (1)
- Each deferred restricted stock unit ("DRSU") is the economic equivalent of one share of PHINIA Inc. common stock and will vest on the one-year anniversary of the grant date. These DRSUs will settle into an equal number of shares of the issuer's Common Stock, including any additional DRSUs acquired as a result of dividend equivalents that have vested, upon the reporting person's termination of board service pursuant to the issuer's Director Deferred Compensation Program and 2023 Stock Incentive Plan. Represents shares of DRSUs acquired following the automatic reinvestment of dividends on outstanding DRSUs held on the dividend record date, as required by the terms of such award.
FAQ
What did PHINIA (PHIN) director Rohan Weerasinghe receive in this Form 4 filing?
PHINIA director Rohan Weerasinghe received a grant of 41 deferred restricted stock units. These units are part of his director compensation and are economically equivalent to common shares, vesting after one year under PHINIA’s Director Deferred Compensation Program and 2023 Stock Incentive Plan.
How do PHINIA (PHIN) deferred restricted stock units work for this director grant?
Each deferred restricted stock unit is the economic equivalent of one PHINIA common share. The 41 units granted to the director vest on the one-year anniversary of the grant and settle into common stock upon termination of board service, consistent with PHINIA’s director compensation programs.
What are Rohan Weerasinghe’s total PHINIA (PHIN) deferred restricted stock unit holdings?
Following the reported grant, Rohan Weerasinghe holds 8,551 deferred restricted stock units. These units represent future rights to receive an equal number of PHINIA common shares, subject to vesting and settlement terms in the Director Deferred Compensation Program and 2023 Stock Incentive Plan.
Is the PHINIA (PHIN) Form 4 transaction an open-market buy or sell?
The reported Form 4 transaction is a grant of 41 deferred restricted stock units, not an open-market buy or sell. It represents compensation awarded to the director, with no purchase or sale of shares on the open market disclosed in this filing.